NT-proBNP is associated with fibulin-1 in Africans: The SAfrEIC study

Savoia, 2010, Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications, Clin Sci, 118, 231, 10.1042/CS20090204 Raizada, 2001, Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension, Mol Cell Biochem, 216, 137, 10.1023/A:1011027231702 Magga, 1994, Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin-and phenylephrine-infused conscious rats, Endocrinology, 134, 2505, 10.1210/endo.134.6.8194476 Tekes, 2007, The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension, J Hum Hypertens, 21, 546, 10.1038/sj.jhh.1002194 Martinez-Rumayor, 2008, Biology of the natriuretic peptides, Am J Cardiol, 101, S3, 10.1016/j.amjcard.2007.11.012 O’Brien, 2005, Practice guidelines of the European society of hypertension for clinic, ambulatory and self blood pressure measurement, J Hypertens, 23, 697, 10.1097/01.hjh.0000163132.84890.c4 Sackner-Bernstein, 2000, The myocardial matrix and the development and progression of ventricular remodeling, Curr Cardiol Rep, 2, 112, 10.1007/s11886-000-0007-4 Argraves, 1990, Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure, J Cell Biol, 111, 3155, 10.1083/jcb.111.6.3155 Cangemi, 2011, Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes, Clin Chem, 57, 1556, 10.1373/clinchem.2011.162966 Laurent, 2007, Molecular determinants of arterial stiffness, Artery Res, 1, 26, 10.1016/j.artres.2007.03.004 Sliwa, 2008, Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study, Lancet, 371, 915, 10.1016/S0140-6736(08)60417-1 Schutte, 2011, Arterial stiffness profiles: investigating various sections of the arterial tree of African and Caucasian people, Clin Exp Hypertens, 33, 511, 10.3109/10641963.2011.561897 Marfell-Jones, 2006 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Wang, 2004, Impact of obesity on plasma natriuretic peptide levels, Circulation, 109, 594, 10.1161/01.CIR.0000112582.16683.EA Olsen, 2005, N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome, Hypertension, 46, 660, 10.1161/01.HYP.0000179575.13739.72 Krupička, 2009, Natriuretic peptides–physiology, pathophysiology and clinical use in heart failure, Physiol Res, 58, 171, 10.33549/physiolres.931461 Neiman, 2011, Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment, J Proteome Res, 10, 4925, 10.1021/pr200286c Zieman, 2005, Mechanisms, pathophysiology, and therapy of arterial stiffness, Arterioscler Thromb Vasc Biol, 25, 932, 10.1161/01.ATV.0000160548.78317.29 Cooley, 2008, Fibulin-1 is required for morphogenesis of neural crest-derived structures, Dev Biol, 319, 336, 10.1016/j.ydbio.2008.04.029 Lakatta, 1993, Cardiovascular regulatory mechanisms in advanced age, Physiol Rev, 73, 413, 10.1152/physrev.1993.73.2.413 Bizbiz, 1997, Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study, Atherosclerosis, 131, 73, 10.1016/S0021-9150(97)06076-0 Uusimaa, 2004, Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension, Int J Cardiol, 97, 251, 10.1016/j.ijcard.2003.10.015 Argraves, 2009, Fibulin-1 and fibrinogen in human atherosclerotic lesions, Histochem Cell Biol, 132, 559, 10.1007/s00418-009-0628-7 Benjamin, 2010, Race, genetics and cardiovascular disease. Cardiovascular disease in racial and ethnic minorities, Contemp Cardiol, 93 Yap, 2004, B-type natriuretic peptide and the right heart, Heart Fail Rev, 9, 99, 10.1023/B:HREV.0000046364.68371.b0 Pemberton, 2000, Deconvolution analysis of cardiac natriuretic peptides during acute volume overload, Hypertension, 36, 355, 10.1161/01.HYP.36.3.355